| Title |
Case Report: Canakinumab for the Treatment of a Patient With COVID-19 Acute Respiratory Distress Syndrome
|
|---|---|
| Published in |
Frontiers in immunology, August 2020
|
| DOI | 10.3389/fimmu.2020.01942 |
| Pubmed ID | |
| Authors |
Massimo Caracciolo, Sebastiano Macheda, Demetrio Labate, Marco Tescione, Stefano La Scala, Eugenio Vadalà, Rosalba Squillaci, Francesco D’Aleo, Antonella Morabito, Cristina Garreffa, Maria Concetta Marciano, Esther N. Oliva |
X Demographics
The data shown below were collected from the profiles of 2 X users who shared this research output. Click here to find out more about how the information was compiled.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Switzerland | 1 | 50% |
| Unknown | 1 | 50% |
Demographic breakdown
| Type | Count | As % |
|---|---|---|
| Members of the public | 2 | 100% |
Mendeley readers
The data shown below were compiled from readership statistics for 103 Mendeley readers of this research output. Click here to see the associated Mendeley record.
Geographical breakdown
| Country | Count | As % |
|---|---|---|
| Unknown | 103 | 100% |
Demographic breakdown
| Readers by professional status | Count | As % |
|---|---|---|
| Student > Bachelor | 12 | 12% |
| Other | 9 | 9% |
| Student > Ph. D. Student | 9 | 9% |
| Researcher | 9 | 9% |
| Student > Doctoral Student | 5 | 5% |
| Other | 17 | 17% |
| Unknown | 42 | 41% |
| Readers by discipline | Count | As % |
|---|---|---|
| Medicine and Dentistry | 28 | 27% |
| Pharmacology, Toxicology and Pharmaceutical Science | 8 | 8% |
| Biochemistry, Genetics and Molecular Biology | 6 | 6% |
| Nursing and Health Professions | 4 | 4% |
| Immunology and Microbiology | 3 | 3% |
| Other | 12 | 12% |
| Unknown | 42 | 41% |
Attention Score in Context
This research output has an Altmetric Attention Score of 1. This is our high-level measure of the quality and quantity of online attention that it has received. This Attention Score, as well as the ranking and number of research outputs shown below, was calculated when the research output was last mentioned on 22 March 2021.
All research outputs
#19,957,118
of 25,387,668 outputs
Outputs from Frontiers in immunology
#22,587
of 31,541 outputs
Outputs of similar age
#309,420
of 424,756 outputs
Outputs of similar age from Frontiers in immunology
#652
of 876 outputs
Altmetric has tracked 25,387,668 research outputs across all sources so far. This one is in the 18th percentile – i.e., 18% of other outputs scored the same or lower than it.
So far Altmetric has tracked 31,541 research outputs from this source. They typically receive more attention than average, with a mean Attention Score of 8.4. This one is in the 21st percentile – i.e., 21% of its peers scored the same or lower than it.
Older research outputs will score higher simply because they've had more time to accumulate mentions. To account for age we can compare this Altmetric Attention Score to the 424,756 tracked outputs that were published within six weeks on either side of this one in any source. This one is in the 23rd percentile – i.e., 23% of its contemporaries scored the same or lower than it.
We're also able to compare this research output to 876 others from the same source and published within six weeks on either side of this one. This one is in the 20th percentile – i.e., 20% of its contemporaries scored the same or lower than it.